Skip to main content

FDA Licenses Linguamatics' Text Mining Platform for Use in Drug Safety Studies

Premium

Linguamatics said this week that the US Food and Drug Administration has licensed its I2E text mining platform to support laboratory research efforts around drug safety.

Specifically, the FDA’s Center for Drug Evaluation and Research will use I2E to mine published literature and drug product labels for information about drug toxicity mechanisms, disease processes, and other biomedical topics.

Linguamatics’ I2E is a natural language processing-based program that enables users to identify, extract, synthesize, and analyze data and relationships between genes, diseases, compounds, and side effects.

Financial details of the agreement were not disclosed

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.